• Home
  • Our Approach
  • Our Progress
  • About
  • Contact Us
  • More
    • Home
    • Our Approach
    • Our Progress
    • About
    • Contact Us
  • Home
  • Our Approach
  • Our Progress
  • About
  • Contact Us

A NEW APPROACH TO DURABLE REMISSION

A NEW APPROACH TO DURABLE REMISSIONA NEW APPROACH TO DURABLE REMISSIONA NEW APPROACH TO DURABLE REMISSION

 Advancing next-generation bispecific nanobody therapeutics for autoimmune diseases, beginning with Crohn's disease. 

A NEW APPROACH TO DURABLE REMISSION

A NEW APPROACH TO DURABLE REMISSIONA NEW APPROACH TO DURABLE REMISSIONA NEW APPROACH TO DURABLE REMISSION

 Advancing next-generation bispecific nanobody therapeutics for autoimmune diseases, beginning with Crohn's disease. 

Beyond Conventional Therapy

 Autoimmune diseases involve complex biological processes that are not always adequately addressed by existing therapies. Jeevan's bispecific nanobody platform is designed to bring complementary therapeutic strategies together in a single molecule, with the potential to deliver more comprehensive disease control. 

Innovation in Crohn's Disease

Jeevan is advancing a differentiated therapeutic approach designed to address the challenges of disease persistence and relapse.

Read Our October 2026 Update

About Jeevan Therapeutics

Mission

Jeevan Therapeutics is developing next-generation bispecific nanobody therapeutics for autoimmune disease, beginning with Crohn's disease. Our lead program is designed to address two complimentary, validated biological pathways involved in disease persistence and relapse, with the goal of achieving deeper and more durable disease control.


Crohn's is our lead indication and where we've built the development strategy. We see broader autoimmune potential for the approach, but we're disciplined about establishing the biology and product profile in Crohn's before moving into additional indications.

Contact Us

contact@jeevantx.com

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Copyright © 2026 Jeevantx - All Rights Reserved.

Powered by

  • Privacy Policy
  • Terms and Conditions

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept